Page last updated: 2024-08-21

myristic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

myristic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, L; Gao, X; He, X; Liu, B; Liu, S; Qiang, J; Wu, Q; Xu, J	1

Other Studies

1 other study(ies) available for myristic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
NMT1 inhibition modulates breast cancer progression through stress-triggered JNK pathway. Cell death & disease, 2018, 11-16, Volume: 9, Issue:12 Topics: Acyltransferases; Animals; Autophagy; Cell Line, Tumor; Cell Proliferation; Disease Progression; Endoplasmic Reticulum Stress; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Myristic Acid; Neoplasm Invasiveness; Protein Processing, Post-Translational; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2018

Article

Year

NMT1 inhibition modulates breast cancer progression through stress-triggered JNK pathway.

Cell death & disease, 2018, 11-16, Volume: 9, Issue:12

Topics: Acyltransferases; Animals; Autophagy; Cell Line, Tumor; Cell Proliferation; Disease Progression; Endoplasmic Reticulum Stress; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Myristic Acid; Neoplasm Invasiveness; Protein Processing, Post-Translational; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2018